Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease

Biological Psychiatry

Volumn 45, Issue 4, 1999, Pages 458-463

  Carney, Robert M ^a   Freedland, Kenneth E ^a   Veith, Richard C ^b   Cryer, Philip E ^a   Skala, Judith A ^a   Lynch, Tiffany ^a   Jaffe, Allan S ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Autonomic nervous system; Coronary heart disease; Depressive disorder

Indexed keywords

NORADRENALIN;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MENTAL DISEASE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR;

AGED; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY DISEASE; DEPRESSIVE DISORDER; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; SEX FACTORS; STATISTICS;

EID: 0033557720     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00049-3     Document Type: Article

References (50)

1. Ahern D.K., Gorkin L., Anderson J.L., Tierney C., Ewart C., Capone R.J., et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol. 66:1990;59-62.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
3. Anda R., Williamson D., Jones D., Macera C., Eaker E., Glassman A., et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 4:1993;285-294.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 4:1961;561-571.
5. Carney R.M., Rich M.W., Freedland K.E., teVelde A., Saini J., Simeone C. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 50:1988;627-633.
6. Carney R.M., Rich M., teVelde A., Saini J., Clark K., Freedland K.E. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res. 32:1988;159-164.
7. Carney R.M., Freedland K.E., Rich M.W., Jaffe A.S. Depression as a risk factor for cardiac events in established coronary heart disease A review of possible mechanisms . Ann Behav Med. 17:1995;142-149.
8. Carney R.M., Saunders R.D., Freedland K.E., Stein P., Rich M.W., Jaffe A.S. Depression is associated with reduced heart rate variability in patients with coronary heart disease. Am J Cardiol. 76:1995;562-564.
9. Carney R.M., Freedland K.E., Eisen S.E., Rich M.W., Jaffe A.S. Depression is associated with poor adherence to medical treatment regimen in elderly cardiac patients. Health Psychol. 14:1995;88-90.
10. Cryer P.E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 303:1980;436-444.
11. Cryer P.E., Silverberg A.B., Santiago J.V., Shah S.D. Plasma catecholamines in diabetes The syndromes of hypoadrenergic and hyperadrenergic postural hypotension . Am J Med. 64:1978;407-416.
12. Dallack G.W., Roose S.P. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry. 51:(suppl 7):1990;4-9.
13. Dawson M.E., Schell A.M., Catania J.J. Autonomic correlates of depression and clinical improvement following electroconvulsive shock therapy. Psychophysiology. 14:1977;569-578.
14. Esler M., Turbott J., Schwarz R., Leonard P., Bobik A., Skews H., et al. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry. 39:1982;285-300.
15. Esler M., Jennings G., Lambert G., Meredith I., Horne M., Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation Source, fate, and functions . Physiol Rev. 70:1990;963-985.
16. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction Impact on 6 month survival . JAMA. 270:1993;1819-1825.
17. Grassi G., Bolla G., Servalle G., Turri C., Lanfranch A., Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci. 92:1997;285-289.
18. Hjalmarson A., Gilpin E.A., Kjekshus J., Schieman G., Nicod P., Henning H. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol. 65:1990;547-553.
19. Imaoka K., Inoue H., Inoue Y., Hazama H., Tanaka T., Yamane N. R-R intervals of ECG in depression. Folia Psychiatr Neurol Jpn. 39:1985;485-488.
20. Kannel W.B., Kannel C., Paffenbarger R.S. Jr, Cupples P.H., Cupples L.A. Heart rate and cardiovascular mortality The Framingham Study . Am Heart J. 113:1987;1489-1494.
21. Kennedy G.J., Hofer M.A., Cohen D., Shindledecker M.A., Fisher J.D. Significance of depression and cognitive impairment in patients undergoing programed stimulation of cardiac arrythmias. Psychosom Med. 49:1987;410-421.
22. Kliks B.R., Burgess M.J., Abildskov J.A. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol. 36:1975;45-49.
23. Ladwig K.H., Kieser M., Konig J., Breithardt G., Borggrefe M. Affective disorders and survival after acute myocardial infarction. Eur Heart J. 12:1991;959-964.
24. Lahmeyer H.W., Bellier S.N. Cardiac regulation and depression. J Psychiatr Res. 21:1987;1-6.
25. Lake C.R., Pickar D., Ziegler M.G., Lipper S., Slater S., Murphy D.L. High plasma NE levels in patients with major affective disorder. Am J Psychiatry. 139:1982;1315-1318.
26. Lesperance F., Frasure-Smith N., Taljic M. Major depression before and after myocardial infarction Its nature and consequences . Psychosom Med. 58:1996;99-110.
27. Linares O.A., Jacques J.A., Zech L.A., Smith M.J., Sanfield J.A., Morrow L.A., et al. Norepinephrine metabolism in humans Kinetic analysis and model . J Clin Invest. 80:1987;1332-1341.
28. Marker J.C., Hirsch I.B., Smith L.J., Parvin C.A., Holloszy J.O., Cryer P.E. Catecholamines in prevention of hypoglycemia during exercise in humans. Am J Physiol. 260:1991;E705-E712.
29. McCance A.J., Forfar J.C. Plasma noradrenaline as an index of sympathetic tone in coronary arterial disease The confounding influence of clearance of noradrenaline . Int J Cardiol. 26:1990;335-342.
30. McCance A.J., Thompson P.A., Forfar J.C. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease. Eur Heart J. 14:1993;751-757.
31. Musselman D., Tomer A., Manatunga A.K., Knight B.T., Porter M.R., Kasey S., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 153:1996;1313-1317.
32. Podrid P.J., Fuchs T., Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation. 82:(suppl 1):1990;103-110.
33. Rechlin T. Are affective disorders associated with alterations of heart rate variability? J Affect Disord. 32:1994;271-275.
34. Robins L.N., Helzer J.E., Croughan J., Williams J.B.W., Spitzer R.L. The NIMH Diagnostic Interview Schedule Version III . 1981;Public Health Service, HHS, Washington, DC. (Publication ADM-T-42-3).
35. Roy A., Pickar D., De Jong J., Karoum F., Linnoila M. NE and its metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry. 45:1988;849-857.
36. Rudorfer M.V., Ross R.J., Linnoila M., Sherer M.A., Potter W.Z. Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Arch Gen Psychiatry. 42:1985;1186-1192.
37. Schleifer S.J., Macari M.M., Slater W., Kahn M., Zucker H., Gorlin R. Predictors of outcome after myocardial infarction Role of depression . Circulation. 2:1986;2-10.
38. Schwartz P.J., Stone H.L. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation. 62:1980;1256-1265.
39. Schwartz P.J., Vanoli E. Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity A new experimental model for the study of antiarrhythmic drugs . J Cardiovasc Pharmacol. 3:1981;1251-1259.
40. Schwartz P.J., Snebold N.G., Brow A.M. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 37:1976;1034-1040.
41. Shah S.D., Tse T.F., Clutter W.E., Cryer P.E. The human sympathochromaffin system. Am J Physiol. 247:1984;E380-E384.
42. Shah S.D., Clutter W.E., Cryer P.E. External and internal standards in the single isotope derivative (radioenzymatic) measurement of plasma NE and epinephrine. J Lab Clin Med. 106:1985;624-629.
43. Siever L., Davis K. Overview Toward a dysregulation hypothesis of depression . Am J Psychiatry. 142:1985;1017-1031.
44. Silverstone P.H. Depression and outcome in acute myocardial infarction. Br Med J. 294:1987;219-220.
45. Veith R.C., Featherstone J.A., Linares O.A., Halter J.B. Age differences in plasma NE kinetics in humans. J Gerontol. 41:1986;319-324.
46. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., et al. Sympathetic nervous system activity in major depression. Arch Gen Psychiatry. 51:1994;411-422.
47. Verrier R.L., Thompson P.L., Lown B. Ventricular vulnerability during sympathetic stimulation Role of heart rate and blood pressure . Cardiovasc Res. 8:1974;602.
48. Wallin B.G., Fagius J. Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol. 50:1988;565-576.
49. Wyatt R.J., Portnoy B., Kupfer D.J., Snyder F., Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry. 24:1971;65-70.
50. Yeragani V.K., Pohl R., Ramesh C., Glitz D., Jung I., Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res. 37:1991;35-46.